Clinical trial reportClinical lung cancerPublished
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked
Regional connection
Verified Author affiliations on the Europe PMC record name Chester County Hospital, Fox Chase Cancer Center, University of Pennsylvania, with Penn Medicine, Temple Health linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Clinical lung cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carboplatin; Proto-Oncogene Proteins; Antineoplastic Combined Chemotherapy Protocols; Smoke; Mutation; Protein-Tyrosine Kinases; Antibodies, Monoclonal, Humanized; ErbB Receptors; Bevacizumab
- PubMed ID
- 37451930
- PubMed Central ID
- PMC11476834
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked